selfie semaglutide Q&A 111: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) Semaglutide vs. Tirzepatide: Weight Loss

NEW YORK, September 9, 2025 (Newswire.com) - This content is for informational purposes only

With our research-driven medical weight loss program, most patients can expect to lose up to 20% of their body weight

However, long-term dietary adjustments may be necessary

At 20 mg/ml, small measurement errors have bigger consequences

The development of these drugs has been based on our evolving understanding of type 2 diabetes and obesity

Personalized Weight Management: A Safer Evidence-Based Alternative PlexusDx provides a precision-medicine approach to weight management that accounts for individual genetic predispositions and metabolic profileswithout forcing off-label medication use onto healthy-weight individuals